While the GPX4/GSH system protects most types of cells from ferroptosis, recent studies suggest that chemoresistant cancer cells with mesenchymal characteristics or drug-tolerant cancer cells are particularly susceptible to ferroptosis8–11. Here, GPX4 is linked to cancer.